| Test item | Gene name |
|---|---|
| Abdominal aortic aneurysm | DAB2IP |
| Abdominal aortic aneurysm | LRP1 |
| Abdominal aortic aneurysm | LDLR |
| Acne | SELL |
| Acne | TGFB2 |
| Acne | FST |
| Acne | DDB2 |
| Acne | OVOL1 |
| Adiponectin levels | ADIPOQ |
| Adiponectin levels | WDR11, FGFR2 |
| Adiponectin levels | ZNF664 |
| Adiponectin levels | CDH13 |
| Adiponectin levels | PEPD |
| Body fat percentage | IRS1 |
| Body fat percentage | SPRY2 |
| Body fat percentage | FTO |
| Scoliosis | GPR126 |
| Scoliosis | BNC2 |
| Scoliosis | LBX1 |
| Scoliosis | FOXA2, PAX1 |
| Cataracts | KCNAB1 |
| Cataracts | CRYAA |
| Age-related hearing impairment | TNFRSF1B |
| Age-related hearing impairment | TNF-α |
| Age-related macular degeneration | CFH |
| Age-related macular degeneration | C4orf14, REST, IGFBP7, POLR2B |
| Age-related macular degeneration | TNFRSF10A, LOC389641 |
| Age-related macular degeneration | HTRA1, LOC105378525 |
| AIDS progression | HLA-C |
| Alcohol dependence | ALDH2 |
| Allergic dermatitis (nickel) | PELI1 |
| Allergic dermatitis (nickel) | NTN4 |
| Allergic rhinitis | GSDMB |
| Allergic sensitization | IL18R1, IL1RL1 |
| Allergic sensitization | LPP, BCL6 |
| Allergic sensitization | FAM114A1, MIR574, TLR10, TLR1, TLR6 |
| Allergic sensitization | IL2, ADAD1, KIAA1109, IL21 |
| Allergic sensitization | TSLP, SLC25A46, WDR36, CAMK4 |
| Allergic sensitization | HLA-DQB1, HLA-DQA1 |
| Allergic sensitization | MYC, PVT1 |
| Allergic sensitization | LRRC32, C11orf30 |
| Allergic sensitization | STAT6 |
| Alopecia areata | HLA-DQA2 |
| Alopecia areata | ULBP3, ULBP6 |
| Anorexia nervosa | SOX2OT |
| Anorexia nervosa | PPP3CA |
| Asthma | LOC729675 |
| Asthma | TSLP |
| Asthma | NOTCH4 |
| Asthma | LOC338591 |
| Asthma | IKZF4 |
| Childhood asthma | HLA-DPB1 |
| Childhood asthma | CDHR3 |
| Childhood asthma | IL33 |
| Childhood asthma | GSDMB |
| Atopic dermatitis | CRCT1, LCE3E, FLG |
| Atopic dermatitis | IL18R1, IL1RL1, IL18RAP |
| Atopic dermatitis | GLB1 |
| Atopic dermatitis | CCDC80, LOC100630917 |
| Atopic dermatitis | TMEM232 |
| Atopic dermatitis | RAD50, IL13 |
| Atopic dermatitis | GPSM3 |
| Atopic dermatitis | CARD11 |
| Atopic dermatitis | ZNF365 |
| Atopic dermatitis | NLRP10, OR10A3 |
| Atopic dermatitis | OVOL1 |
| Atopic dermatitis | ACTL9 |
| Atopic dermatitis | CYP24A1, PFDN4 |
| Atrial fibrillation | IL6R |
| Atrial fibrillation | PRRX1 |
| Atrial fibrillation | PITX2 |
| Atrial fibrillation | CAV1 |
| Atrial fibrillation | C9orf3 |
| Atrial fibrillation | ZFHX3 |
| Axial length | GJD2 |
| Axial length | WNT7B |
| Barrett esophagus | OR2D12, OR2D13, MHC |
| Barrett esophagus | FOXF1, LOC732275 |
| Basal cell carcinoma | RCC2, PADI6 |
| Basal cell carcinoma | RHOU |
| Basal cell carcinoma | TERT |
| Basal cell carcinoma | KLF14 |
| Basal cell carcinoma | RGS22 |
| Basal cell carcinoma | GATA3, RP11-428L9.1, RP11-428L9.2 |
| Basal cell carcinoma | MC1R |
| Basal cell carcinoma | TP53 |
| Basal cell carcinoma | TGM3 |
| Bilirubin levels | UGT1A1 |
| Bilirubin levels | SLCO1B3, LST3 |
| Bladder cancer | TACC3 |
| Bladder cancer | CASC11 |
| Bladder cancer | PSCA |
| Bladder cancer | CLK3, CYP1A2 |
| Bladder cancer | LOC105372093, SLC14A1 |
| Bladder cancer | APOBEC3A |
| Body mass index | SEC16B |
| Body mass index | CDKAL1 |
| Body mass index | KLF9 |
| Body mass index | BDNF |
| Body mass index | FTO |
| Body mass index | MC4R |
| Body mass index | GIPR |
| Breast cancer | ZC3H11A |
| Breast cancer | intergenic |
| Breast cancer | SIAH2 |
| Breast cancer | ARRDC3 |
| Breast cancer | ESR1 |
| Breast cancer | ZNF365 |
| Breast cancer | FGFR2 |
| Breast cancer | ATF7IP |
| Breast cancer | PRC1 |
| Breast cancer | TOX3, LOC643714 |
| Breast cancer | ANKLE1 |
| Brugada syndrome | SCN10A |
| Brugada syndrome | HEY2 |
| Coffee consumption | AHR |
| Coffee consumption | CYP1A2 |
| Calcium levels | CASR |
| Celiac disease | RGS1 |
| Celiac disease | AHSA2 |
| Celiac disease | IL18RAP |
| Celiac disease | CCR3 |
| Celiac disease | IL12A |
| Celiac disease | LPP |
| Celiac disease | IL2 |
| Celiac disease | HLA-DQ |
| Celiac disease | TNFAIP3 |
| Celiac disease | TAGAP |
| Celiac disease | ETS1 |
| Celiac disease | SH2B3 |
| Cervical cancer | GSDMB |
| Chronic hepatitis B | HLA-DPA1 |
| Chronic hepatitis B | HLA-DPB1 |
| Chronic hepatitis B | HLA-DQB1 |
| Chronic hepatitis B | HLA-DQB2 |
| Chronic hepatitis C | HLA-DQB1, HLA-DQA1 |
| Chronic hepatitis C | DEPDC5 |
| Chronic kidney disease | MECOM |
| Chronic kidney disease | ALPK1 |
| Chronic kidney disease | BTN2A1 |
| Chronic kidney disease | MHC region |
| Chronic kidney disease | UNCX |
| Chronic kidney disease | UCP2 |
| Chronic kidney disease | MMP1 |
| Chronic kidney disease | WDR72 |
| Chronic kidney disease | UMOD |
| Chronic kidney disease | MAF |
| Chronic kidney disease | GNAS |
| Chronic obstructive pulmonary disease | FAM13A |
| Chronic obstructive pulmonary disease | HHIP |
| Chronic obstructive pulmonary disease | CHRNA3 |
| Caffeine consumption | AHR |
| Caffeine consumption | POR |
| Caffeine consumption | CYP1A1/CYP1A2 |
| Colorectal cancer | CTNNB1 |
| Colorectal cancer | PITX1 |
| Colorectal cancer | CDKN1A |
| Colorectal cancer | SLC22A3 |
| Colorectal cancer | EIF3H |
| Colorectal cancer | intergenic |
| Colorectal cancer | VTI1A |
| Colorectal cancer | MYRF, FADS1, FADS2, FEN1 |
| Colorectal cancer | C11orf93 |
| Colorectal cancer | CCND2 |
| Colorectal cancer | SMAD7 |
| Colorectal cancer | HAO1 |
| Corneal astigmatism | PDGFRA |
| Corneal curvature | MTOR |
| Corneal curvature | CMPK1 |
| Corneal curvature | PDGFRA |
| Corneal curvature | RBP3 |
| Central corneal thickness | COL8A2 |
| Central corneal thickness | COL4A3 |
| Central corneal thickness | FNDC3B |
| Central corneal thickness | NR3C2 |
| Central corneal thickness | ADAMTS6 |
| Central corneal thickness | IBTK |
| Central corneal thickness | TMEM248 /C7orf42 |
| Central corneal thickness | MPDZ |
| Central corneal thickness | LPAR1 |
| Central corneal thickness | COL5A1 |
| Central corneal thickness | ARID5B |
| Central corneal thickness | ARHGAP20 |
| Central corneal thickness | GLT8D2 |
| Central corneal thickness | FGF9 |
| Central corneal thickness | FOXO1 |
| Central corneal thickness | TJP1 |
| Central corneal thickness | SMAD3 |
| Central corneal thickness | AKAP13 |
| Central corneal thickness | LRRK1 |
| Central corneal thickness | ZNF469 |
| Central corneal thickness | PMP22 |
| Coronary artery calcification | PHACTR1 |
| Coronary artery calcification | CDKN2B |
| Coronary artery disease | PPAP2B |
| Coronary artery disease | SORT1 |
| Coronary artery disease | MIA3 |
| Coronary artery disease | GGCX |
| Coronary artery disease | EDNRA |
| Coronary artery disease | PHACTR1 |
| Coronary artery disease | HLA, DRB-DQB |
| Coronary artery disease | LPA |
| Coronary artery disease | 9p21 |
| Coronary artery disease | CDKN2B |
| Coronary artery disease | CXCL12 |
| Coronary artery disease | PDGFD |
| Coronary artery disease | SH2B3 |
| Coronary artery disease | ALDH2 |
| Coronary artery disease | FLT1 |
| Coronary artery disease | LDLR |
| Coronary artery disease | ZNF507 |
| Coronary artery disease | KCNE2 |
| Coronary spasm | eNOS |
| Coronary spasm | intergenic |
| Cotinine glucuronidation | UGT2B10 |
| C-reactive protein Levels | CRP |
| C-reactive protein Levels | IL6 |
| C-reactive protein Levels | HNF1A |
| Crohn disease | TBC1D1 |
| Crohn disease | HLA-DRB1, HLA-DQB1 |
| Crohn disease | TNFSF15 |
| Crohn disease | ELF1 |
| Crohn disease | STAT3 |
| Dengue shock syndrome | MICB |
| Dengue shock syndrome | PLCE1 |
| Dental caries | VDR |
| Dental caries | DLX3 |
| Gestational diabetes | IGF2BP2 |
| Gestational diabetes | CDKAL1 |
| Gestational diabetes | MTNR1B |
| Diabetic retinopathy | TBX18 |
| Diabetic retinopathy | MYSM1 |
| Diabetic retinopathy | PLXDC2 |
| Diastolic blood pressure | CASZ1 |
| Diastolic blood pressure | ST7L |
| Diastolic blood pressure | FGF5 |
| Diastolic blood pressure | ENPEP |
| Diastolic blood pressure | NT5C2, CNNM2, CYP17A1 |
| Diastolic blood pressure | ATP2B1 |
| Diastolic blood pressure | RPL6, ALDH2, PTPN11 |
| Diastolic blood pressure | TBX3 |
| Lumbar degenerative disc disease | CHST3 |
| Drinking behavior | ALDH2 |
| Duodenal ulcer | PSCA |
| Duodenal ulcer | ABO |
| Dupuytren disease | WNT4 |
| Dupuytren disease | SFRP4 |
| Dupuytren disease | SULF1 |
| Dupuytren disease | RSPO2 |
| Dupuytren disease | DUXA |
| Dupuytren disease | MAFB |
| Dupuytren disease | WNT7B |
| Earwax type | ABCC11 |
| Endometrial cancer | HNF1B |
| Endometrial cancer | XRCC1 |
| Endometriosis | WNT4 |
| Endometriosis | RHOU |
| Endometriosis | GREB1 |
| Endometriosis | none |
| Endometriosis | IL1A |
| Endometriosis | intergenic |
| Endometriosis | CDKN2BAS |
| Endometriosis | CDKN2B |
| Endometriosis | VEZT |
| Eosinophil counts | GATA2 |
| Eosinophil counts | HLA-DRB1, HLA-DQB1 |
| Eosinophil counts | HBS1L |
| Epithelial ovarian cancer | HAGLR/HOXD-AS1 |
| Epithelial ovarian cancer | TIPARP |
| Epithelial ovarian cancer | MIR146A |
| Epithelial ovarian cancer | MYC |
| Epithelial ovarian cancer | none |
| Epithelial ovarian cancer | COL15A1 |
| Epithelial ovarian cancer | SURF6, ABO |
| Epithelial ovarian cancer | MLLT10 |
| Epithelial ovarian cancer | ANKRD30A |
| Epithelial ovarian cancer | SRGAP1 |
| Epithelial ovarian cancer | SKAP1 |
| Epithelial ovarian cancer | BABAM1 |
| Esophageal cancer | ST6GAL1 |
| Esophageal cancer | ADH6, ADH1B |
| Esophageal cancer | PDE4D |
| Esophageal cancer | TMEM173 |
| Esophageal cancer | UNC5CL |
| Esophageal cancer | PLCE1 |
| Esophageal cancer | BRAP, ALDH2 |
| Esophageal cancer | ANP32A |
| Esophageal cancer | HEATR3 |
| Esophageal cancer | HAP1 |
| Esophageal cancer | RUNX1 |
| Esophageal cancer | CHEK2 |
| Ewing sarcoma | TARDBP |
| Ewing sarcoma | EGR2 |
| Ewing sarcoma | SRP14 |
| Exfoliation syndrome | LOXL1 |
| Exfoliation syndrome | CACNA1A |
| Facial pigmentation | IRF4 |
| Facial pigmentation | BNC2 |
| Facial pigmentation | MC1R |
| Facial pigmentation | RALY |
| Fasting plasma glucose | SIX2, SIX3 |
| Fasting plasma glucose | G6PC2, ABCC11 |
| Fasting plasma glucose | CDKAL1 |
| Fasting plasma glucose | GCK |
| Fasting plasma glucose | SLC30A8 |
| Fasting plasma glucose | CDKN2A, CDKN2B |
| Fasting plasma glucose | MTNR1B |
| Fasting plasma glucose | FOXA2 |
| Fibrinogen levels | LEPR |
| Fibrinogen levels | IL6R |
| Fibrinogen levels | NLRP3 |
| Fibrinogen levels | IL1F10 |
| Fibrinogen levels | CPS1 |
| Fibrinogen levels | FARP2 |
| Fibrinogen levels | PCCB |
| Fibrinogen levels | HGFAC, LRPAP1 |
| Fibrinogen levels | FGB |
| Fibrinogen levels | IRF1 |
| Fibrinogen levels | PLEC |
| Fibrinogen levels | JMJD1C |
| Fibrinogen levels | TTC17 |
| Fibrinogen levels | DIP2B |
| Fibrinogen levels | SH2B3 |
| Fibrinogen levels | SPPL2A |
| Fibrinogen levels | CHD9 |
| Fibrinogen levels | CD300LF |
| Follicle stimulating hormone levels in Men | CYP19A1 |
| Forced vital capacity | EFEMP1 |
| Forced vital capacity | BMP6 |
| Forced vital capacity | PRDM11 |
| Forced vital capacity | WWOX |
| Forced vital capacity | KCNJ2 |
| Freckles | IRF4 |
| Freckles | BNC2 |
| Freckles | MC1R |
| Freckles | ASIP |
| Gallbladder cancer | DCC |
| Gallstones | ABCG8 |
| Gastric cancer | MUC1 |
| Gastric cancer | PRKAA1 |
| Gastric cancer | UNC5CL |
| Gastric cancer | PSCA |
| Gastric cancer | PLCE1 |
| Glaucoma (primary open-angle) | NCKAP5 |
| Glaucoma (primary open-angle) | CDKN2B |
| Glaucoma (primary open-angle) | SIX6 |
| Glioma | TERT |
| Glioma | CCDC26 |
| Glioma | CDKN2B-AS1 |
| Glioma | PHLDB1 |
| Glioma | TP53 |
| Glioma | RTEL1 |
| Gout | GCKR |
| Gout | SLC2A9 |
| Gout | ABCG2 |
| Gout | CNIH-2 |
| Gout | MYL2, CUX2 |
| Graves disease | HLA-A |
| Graves disease | HLA-J |
| Graves disease | ABCF1 |
| Graves disease | HCG22 |
| Graves disease | C6orf10/TSBP |
| Graves disease | ITPR3 |
| Graves disease | MLN |
| HDL cholesterol | LPL |
| HDL cholesterol | ABCA1 |
| HDL cholesterol | APOA1 |
| HDL cholesterol | C12orf51 |
| HDL cholesterol | LIPC |
| HDL cholesterol | CETP |
| HDL cholesterol | LCAT |
| HDL cholesterol | LIPG |
| Heart rate | CD46 |
| Heart rate | CCDC141 |
| Heart rate | GNB4 |
| Heart rate | SLC35F1 |
| Heart rate | GJA1 |
| Heart rate | ACHE |
| Heart rate | FADS1 |
| Heart rate | SYT10 |
| Heart rate | MYH6 |
| Heart rate | FLRT2 |
| Heart rate | HCN4 |
| Heart rate | KIAA1755 |
| Height | EFEMP1 |
| Height | DIS3L2 |
| Height | ZBTB38 |
| Height | NCAPG |
| Height | HMGA1 |
| Height | PLAG1 |
| Height | QSOX2, LHX3 |
| Height | IGF1 |
| Hepatitis C induced liver cirrhosis | C6orf10/TSBP |
| Hepatitis C induced liver cirrhosis | intergenic |
| Hepatocellular carcinoma | MICA |
| Hoarding | LCA5 |
| Hodgkin lymphoma | REL |
| Hodgkin lymphoma | EOMES |
| Hodgkin lymphoma | HLA-DRA |
| Hodgkin lymphoma | PVT1 |
| Hodgkin lymphoma | GATA3 |
| Hodgkin lymphoma | TCF3 |
| Homocysteine levels | MTHFR |
| Homocysteine levels | MTR |
| Homocysteine levels | MUT |
| Homocysteine levels | NOX4 |
| Homocysteine levels | DPEP1 |
| Homocysteine levels | CBS |
| Homocysteine levels | CPS1 |
| Hyperopia | TOX |
| Hyperopia | GJD2 |
| Hypersomnia (HLA-DQB1*06:02 negative) | BCL11A |
| Hypersomnia (HLA-DQB1*06:02 negative) | NCKAP5 |
| Hypersomnia (HLA-DQB1*06:02 negative) | TAS2R1 |
| Hypersomnia (HLA-DQB1*06:02 negative) | PPP2R4 |
| Hypersomnia (HLA-DQB1*06:02 negative) | SPRED1 |
| Hypertension | CASZ1 |
| Hypertension | MOV10 |
| Hypertension | ADD2 |
| Hypertension | FGF5 |
| Hypertension | CYP21A2 |
| Hypertension | CYP17A1 |
| Hypertension | M6PR |
| Hypertension | ATP2B1 |
| Hypertension | WSCD2/KIAA0789 |
| Hypertension | CSK |
| Hypothyroidism | PTPN22 |
| Hypothyroidism | FOXE1 |
| Hypothyroidism | SH2B3 |
| IgE levels | ANXA3 |
| IgE levels | HLA-C |
| IgG levels | TNFSF13 |
| IgG levels | TNFRSF13B |
| IgM levels | TNFSF13 |
| IgM levels | TNFRSF13B |
| Inflammatory bowel disease | UCN |
| Inflammatory bowel disease | TBC1D1 |
| Inflammatory bowel disease | IL12B |
| Inflammatory bowel disease | NFKBIL1 |
| Inflammatory bowel disease | TNFSF15 |
| Inflammatory bowel disease | CREM |
| Inflammatory bowel disease | NKX2-3 |
| Inflammatory bowel disease | ELF1 |
| Inflammatory bowel disease | GPR65 |
| Inflammatory bowel disease | STAT3 |
| Inguinal hernia | EFEMP1 |
| Inguinal hernia | ADAMTS6 |
| Inguinal hernia | EBF2 |
| Inguinal hernia | WT1 |
| Intracranial aneurysm | PLCL1 |
| Intracranial aneurysm | EDNRA |
| Intracranial aneurysm | SOX17 |
| Intracranial aneurysm | CDKN2A, CDKN2B |
| Intracranial aneurysm | CNNM2 |
| Intracranial aneurysm | STARD13 |
| Intracranial aneurysm | RBBP8 |
| Intrahepatic cholestasis of pregnancy | ABCB11 |
| Irritable bowel syndrome | HES6 |
| Irritable bowel syndrome | FGF2 |
| Irritable bowel syndrome | KDELR2 |
| Irritable bowel syndrome | PCDH15 |
| Stroke | PITX2 |
| Stroke | HDAC9 |
| Stroke | NINJ2 |
| Stroke | ALDH2 |
| Stroke | ZFHX3 |
| Stroke | LLGL2 |
| Stroke | CELSR1 |
| Kawasaki disease | MLF1IP |
| Kawasaki disease | HLA-DOB |
| Kawasaki disease | BLK |
| Kawasaki disease | MIA |
| Kawasaki disease | CD40 |
| Keloid | intergenic |
| Keloid | none |
| Keloid | FOXL2 |
| Keloid | NEDD4 |
| Large B-cell lymphoma | LNX2 |
| Large B-cell lymphoma | CDC42BPB |
| Laryngeal squamous cell carcinoma | AIF1 |
| Laryngeal squamous cell carcinoma | FADS1 |
| Laryngeal squamous cell carcinoma | TBX5 |
| LDL cholesterol | PCSK9 |
| LDL cholesterol | CELSR2-PSRC1-SORT1 |
| LDL cholesterol | APOB |
| LDL cholesterol | HMGCR |
| LDL cholesterol | TIMD4 |
| LDL cholesterol | HLA-C |
| LDL cholesterol | SURF6, ABO |
| LDL cholesterol | FADS1 |
| LDL cholesterol | HPR |
| LDL cholesterol | LDLR |
| LDL cholesterol | APOE |
| Leprosy | IL23R |
| Leprosy | HLA-DR-DQ |
| Leprosy | RIPK2 |
| Leprosy | TNFSF15 |
| Leprosy | LACC1 |
| Leprosy | NOD2 |
| Liver enzyme levels (ALT) | HSD17B13 |
| Liver enzyme levels (ALT) | CPN1 |
| Liver enzyme levels (ALT) | PNPLA3 |
| Liver enzyme levels (ALP) | NBPF3 |
| Liver enzyme levels (ALP) | ABCB11 |
| Liver enzyme levels (ALP) | ALDH5A1 |
| Liver enzyme levels (ALP) | PPP1R3B |
| Liver enzyme levels (ALP) | ALDOB |
| Liver enzyme levels (ALP) | ABO |
| Liver enzyme levels (ALP) | JMJD1C, NRBF2 |
| Liver enzyme levels (ALP) | FADS1 |
| Liver enzyme levels (ALP) | ST3GAL4 |
| Liver enzyme levels (ALP) | HP |
| Liver enzyme levels (ALP) | ASGR1 |
| Liver enzyme levels (ALP) | FUT2 |
| Liver enzyme levels (ALP) | ABHD12 |
| Liver enzyme levels (γGTP) | EPHA2 |
| Liver enzyme levels (γGTP) | KYAT1/CCBL2 |
| Liver enzyme levels (γGTP) | DENND2D |
| Liver enzyme levels (γGTP) | EFNA1 |
| Liver enzyme levels (γGTP) | GCKR, C2orf16 |
| Liver enzyme levels (γGTP) | STAT4 |
| Liver enzyme levels (γGTP) | EFHD1 |
| Liver enzyme levels (γGTP) | SLC2A2 |
| Liver enzyme levels (γGTP) | ZNF827 |
| Liver enzyme levels (γGTP) | CDH6 |
| Liver enzyme levels (γGTP) | ITGA1 |
| Liver enzyme levels (γGTP) | MLIP |
| Liver enzyme levels (γGTP) | MLXIPL |
| Liver enzyme levels (γGTP) | DLG5 |
| Liver enzyme levels (γGTP) | HNF1A |
| Liver enzyme levels (γGTP) | EXOC3L4/C14orf73 |
| Liver enzyme levels (γGTP) | RORA |
| Liver enzyme levels (γGTP) | CD276 |
| Liver enzyme levels (γGTP) | DYNLRB2 |
| Liver enzyme levels (γGTP) | FLJ37644, SOX9 |
| Liver enzyme levels (γGTP) | ATP8B1 |
| Liver enzyme levels (γGTP) | NEDD4L |
| Liver enzyme levels (γGTP) | FUT2 |
| Liver enzyme levels (γGTP) | MICAL3 |
| Liver enzyme levels (γGTP) | GSTT1 |
| Longevity | FOXO3 |
| Longevity | PON1 |
| Longevity | ND2 |
| Lung adenocarcinoma | EPAS1 |
| Lung adenocarcinoma | TP63 |
| Lung adenocarcinoma | TERT |
| Lung adenocarcinoma | BTNL2 |
| Lung adenocarcinoma | BPTF |
| Lung cancer (Squamous cell carcinoma) | TP63 |
| Lung cancer (Squamous cell carcinoma) | TERT |
| Lung cancer (Squamous cell carcinoma) | ROS1 |
| Lung cancer (Squamous cell carcinoma) | VTI1A |
| Lung cancer (Squamous cell carcinoma) | SLC17A8 |
| Lung cancer (Squamous cell carcinoma) | MIPEP |
| Lung cancer (Squamous cell carcinoma) | MTMR3 |
| Magnesium levels | MUC1 |
| Magnesium levels | MDS1 |
| Magnesium levels | SHROOM3 |
| Magnesium levels | TRPM6 |
| Magnesium levels | DCDC5 |
| Magnesium levels | ATP2B1 |
| Mean corpuscular hemoglobin | PTPRC |
| Mean corpuscular hemoglobin | THRB |
| Mean corpuscular hemoglobin | TFRC |
| Mean corpuscular hemoglobin | PDGFRA, HK1 |
| Mean corpuscular hemoglobin | BYSL, USP49, CCND3, MED20 |
| Mean corpuscular hemoglobin | C6orf182, CD164 |
| Mean corpuscular hemoglobin | HBS1L, MYB |
| Mean corpuscular hemoglobin | CITED2 |
| Mean corpuscular hemoglobin | RCL1 |
| Mean corpuscular hemoglobin | MARCH8 |
| Mean corpuscular hemoglobin | NCOA4 |
| Mean corpuscular hemoglobin | DENND4A |
| Mean corpuscular hemoglobin | HBA1 |
| Mean corpuscular hemoglobin | TMPRSS6 |
| Mean corpuscular hemoglobin | TYMP |
| Mean corpuscular hemoglobin concentration | TMEM79 |
| Mean corpuscular hemoglobin concentration | SLC12A7 |
| Mean corpuscular hemoglobin concentration | HBS1L, MYB |
| Mean corpuscular hemoglobin concentration | ABO |
| Mean corpuscular hemoglobin concentration | ALDH2 |
| Mean corpuscular hemoglobin concentration | CDT1 |
| Mean corpuscular hemoglobin concentration | TMPRSS6 |
| Mean corpuscular volume | TRIM58 |
| Mean corpuscular volume | THRB |
| Mean corpuscular volume | TFRC |
| Mean corpuscular volume | PDGFRA, HK1 |
| Mean corpuscular volume | BYSL, USP49, CCND3, MED20 |
| Mean corpuscular volume | C6orf182, CD164 |
| Mean corpuscular volume | HBS1L, MYB |
| Mean corpuscular volume | CITED2 |
| Mean corpuscular volume | XPO7 |
| Mean corpuscular volume | RCL1 |
| Mean corpuscular volume | MARCH8 |
| Mean corpuscular volume | TIMM23 |
| Mean corpuscular volume | RBM38 |
| Mean corpuscular volume | UBE2L3 |
| Mean corpuscular volume | TMPRSS6 |
| Mean platelet volume | DNM3 |
| Mean platelet volume | TMCC2 |
| Mean platelet volume | EHD3 |
| Mean platelet volume | ARHGEF3 |
| Mean platelet volume | PIK3CG |
| Mean platelet volume | JMJD1C |
| Mean platelet volume | VWF |
| Mean platelet volume | COPZ1 |
| Mean platelet volume | WDR66 |
| Mean platelet volume | EXOC3L4/C14orf73 |
| Mean platelet volume | CD226 |
| Melanoma | ARNT |
| Melanoma | CASP8 |
| Melanoma | TERT, CLPTM1L |
| Melanoma | MTAP |
| Melanoma | TYR |
| Melanoma | OCA2 |
| Melanoma | MC1R |
| Melanoma | PIGU/CDC91L1 |
| Melanoma | MX2 |
| Melanoma | intergenic |
| Menopause (age at onset) | RHBDL2 |
| Menopause (age at onset) | UIMC1 |
| Menopause (age at onset) | ASH2L |
| Menopause (age at onset) | POLG |
| Menopause (age at onset) | BRSK1 |
| Menopause (age at onset) | BRSK1, TMEM224, SUV420H2 |
| Menopause (age at onset) | TMEM150B |
| Menopause (age at onset) | NLRP11 |
| Migraine | PRDM16 |
| Migraine | TSPAN2 |
| Migraine | MEF2D |
| Migraine | TRPM8 |
| Migraine | PHACTR1 |
| Migraine | FHL5 |
| Migraine | SUGCT/c7orf10 |
| Migraine | ASTN2 |
| Migraine | LRP1 |
| Migraine without aura | TRPM8 |
| Migraine without aura | PHACTR1 |
| Migraine without aura | FHL5 |
| Migraine without aura | MMP16 |
| Migraine without aura | LRP1 |
| Mitral valve prolapse | TNS1 |
| Mitral valve prolapse | LMCD1 |
| Mitral valve prolapse | SIPA1L1 |
| Mitral valve prolapse | SMG6 |
| Mitral valve prolapse | MN1 |
| Monocyte count | ITGA4 |
| Monocyte count | HLA-Cw |
| Monocyte count | GSDMC/MLZE |
| Monocyte count | STXBP6 |
| Motion sickness | PRDM16 |
| Motion sickness | RWDD3 |
| Motion sickness | GPD2 |
| Motion sickness | UBE2E2 |
| Motion sickness | PVRL3 |
| Motion sickness | CPNE4 |
| Motion sickness | NLGN1 |
| Motion sickness | MUTED |
| Motion sickness | AUTS2 |
| Motion sickness | ACO1 |
| Motion sickness | GPR26 |
| Motion sickness | CBLN4 |
| Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma) | LRFN2 |
| Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma) | DNAH11 |
| Multiple myeloma | MYNN |
| Multiple myeloma | ELL2 |
| Multiple myeloma | PSORS1C1 |
| Multiple myeloma | DNAH11 |
| Multiple myeloma | TNFRSF13B |
| Multiple myeloma | CBX7 |
| Myocardial infarction | PLCL2 |
| Myocardial infarction | intergenic |
| Myocardial infarction | ALDH2 |
| Myocardial infarction | AP3D1 |
| Myopia | CTNND2 |
| Myopia | LOC399959, BLID |
| Myopia | WNT7B |
| Kidney stones | RGS14 |
| Kidney stones | INMT |
| Kidney stones | DGKH |
| Neutrophil count | CDK6 |
| Neutrophil count | CSF3 |
| Neutrophil count | PLCB4 |
| Nicotine dependence | CHRNB3 |
| Nicotine dependence | ANKK1 |
| Nicotine dependence | CHRNA5, CHRNA3, CHRNB4 |
| Nicotine dependence | CHRNA4 |
| Non-albumin protein levels | ANXA3 |
| Non-albumin protein levels | TNFSF13 |
| Non-albumin protein levels | TNFRSF13B |
| Non-alcoholic fatty liver disease | PNPLA3 |
| Non-cardia gastric cancer | MUC1 |
| Non-cardia gastric cancer | PRKAA1 |
| Non-cardia gastric cancer | lnc-POLR3G-4 |
| Non-cardia gastric cancer | UNC5CL |
| Non-cardia gastric cancer | PSCA |
| Non-obstructive azoospermia | MMEL1, PEX10 |
| Non-obstructive azoospermia | PRMT6 |
| Non-obstructive azoospermia | SOX5 |
| Non-obstructive azoospermia | LOC100289473 |
| Non-small cell lung cancer | C3orf21 |
| Obstructive sleep apnea | NRG1 |
| Orthostatic hypotension | CTNNA2 |
| Osteoarthritis | DVWA |
| Osteoarthritis | HLA-DQB1 |
| Osteoarthritis | DUS4L |
| Osteoporosis | FONG |
| Osteoporosis | MECOM |
| Osteoporosis | ALDH7A1 |
| Paget disease of bone | CSF1, EPS8LS |
| Paget disease of bone | NUP205 |
| Paget disease of bone | TM7SF4 |
| Paget disease of bone | OPTN |
| Paget disease of bone | RIN3 |
| Paget disease of bone | PML |
| Paget disease of bone | TNFRSF11A |
| Pancreatic cancer | NR5A2 |
| Pancreatic cancer | ADIPOQ |
| Pancreatic cancer | FOXQ1 |
| Pancreatic cancer | DPP6 |
| Pancreatic cancer | KCNQ1 |
| Pancreatic cancer | BICD1 |
| Pancreatitis | KCNA3 |
| Pancreatitis | PRSS1 |
| Pancreatitis | CLDN2 |
| Peanut allergy | HLA-DQB1, HLA-DQA2 |
| Periodontitis | CSF1 |
| Periodontitis | KCNQ5 |
| Periodontitis | GPR141, NME8 |
| Peripheral artery disease | EDNRA |
| Peripheral artery disease | HDAC9 |
| Peripheral artery disease | IPO5, RAP2A |
| Phosphorus levels | NBPF3-ALPL |
| Phosphorus levels | CSTA |
| Phosphorus levels | IP6K3 |
| Phosphorus levels | PDE7B |
| Phosphorus levels | C12orf4（FGF6） |
| Adrenic acid levels | FADS1 |
| Arachidonic acid levels | FADS2 |
| Dihomo-gamma-linolenic acid levels | FADS1 |
| Gamma-linolenic acid levels | FADS1 |
| Linoleic acid levels | FADS1 |
| Platelet count | THPO, CHRD |
| Platelet count | BAK1 |
| Platelet count | HBS1L, MYB |
| Platelet count | RCL1 |
| Platelet count | SH2B3 |
| Platelet count | GP1BA |
| Polycystic ovary syndrome | THADA |
| Polycystic ovary syndrome | LHCGR |
| Polycystic ovary syndrome | FSHR |
| Polycystic ovary syndrome | C9orf3 |
| Polycystic ovary syndrome | DENND1A |
| Polycystic ovary syndrome | YAP1 |
| Polycystic ovary syndrome | RAB5B, SUOX |
| Polycystic ovary syndrome | HMGA2 |
| Polycystic ovary syndrome | TOX3 |
| Polycystic ovary syndrome | INSR |
| Polycystic ovary syndrome | SUMO1P1 |
| Post-traumatic stress disorder | PRTFDC1 |
| Electrocardiogram (PR interval) | SLC8A1 |
| Electrocardiogram (PR interval) | EXOG, SCN5A, SCN10A |
| Electrocardiogram (PR interval) | CAV1, CAV2 |
| Prostate cancer | none |
| Prostate cancer | intergenic |
| Prostate cancer | GPRC6A, RFX6 |
| Prostate cancer | NKX3.1 |
| Prostate cancer | MSMB |
| Prostate cancer | HNF1B |
| Prostate-specific antigen levels | SLC45A3 |
| Prostate-specific antigen levels | MSMB |
| Prostate-specific antigen levels | KLK3 |
| Psoriasis | LCE3D |
| Psoriasis | IFIH1 |
| Psoriasis | IL12B |
| Psoriasis | MHC |
| Psoriatic arthritis | IL23R, C1orf141 |
| Psoriatic arthritis | IL12B, ADRA1B, RNF145 |
| Psoriatic arthritis | HLA-C, HLA-B, HLA, MHC |
| Psoriatic arthritis | TRAF3IP2 |
| Pulmonary emphysema | SERPINE2 |
| Pulmonary emphysema | FUT8 |
| Electrocardiogram (QRS duration) | PRDM16 |
| Electrocardiogram (QRS duration) | PRDM6 |
| Electrocardiogram (QRS duration) | SETBP1 |
| Electrocardiogram (QT interval) | RNF207 |
| Electrocardiogram (QT interval) | NOS1AP |
| Electrocardiogram (QT interval) | ATP1B1 |
| Electrocardiogram (QT interval) | SLC8A1 |
| Electrocardiogram (QT interval) | SCN5A |
| Electrocardiogram (QT interval) | PLN |
| Electrocardiogram (QT interval) | KCNH2 |
| Electrocardiogram (QT interval) | KCNQ1 |
| Electrocardiogram (QT interval) | LITAF |
| Electrocardiogram (QT interval) | NDRG4 |
| Electrocardiogram (QT interval) | KCNJ2 |
| Red blood cell count | PRKCE |
| Red blood cell count | PDGFRA, HK1 |
| Red blood cell count | TERT |
| Red blood cell count | BYSL, USP49, CCND3, MED20 |
| Red blood cell count | C6orf182, CD164 |
| Red blood cell count | HBS1L, MYB |
| Red blood cell count | ABO |
| Red blood cell count | CCND2 |
| Restless legs syndrome | MEIS1 |
| Restless legs syndrome | BTBD9 |
| Restless legs syndrome | PTPRD |
| Restless legs syndrome | MAP2K5, SKOR1 |
| Restless legs syndrome | TOX3, BC034767 |
| Retinol levels | RBP4 |
| Retinol levels | TTR |
| Rheumatoid Arthritis | PADI4 |
| Rheumatoid Arthritis | ANXA3 |
| Rheumatoid Arthritis | CSF2 |
| Rheumatoid Arthritis | HLA-DRB1 |
| Rheumatoid Arthritis | NFKBIE |
| Rheumatoid Arthritis | TNFAIP3 |
| Rheumatoid Arthritis | CCR6 |
| Rheumatoid Arthritis | ARID5B |
| Rheumatoid Arthritis | PDE2A, ARAP1 |
| Rheumatoid Arthritis | AIRE |
| Rhinosinusitis | RYBP |
| Rhinosinusitis | LOC100287329, LTA |
| Rhinosinusitis | AOAH |
| Serum albumin level | GCKR |
| Serum albumin level | SERPINF2, WDR81 |
| Serum albumin level | TNFRSF11A, ZCCHC2 |
| Serum albumin level | FCGRT, RPS11 |
| Serum alpha1-antitrypsin levels | GCKR |
| Serum alpha1-antitrypsin levels | ALDH2 |
| Serum alpha1-antitrypsin levels | HNF1A |
| Serum alpha1-antitrypsin levels | SERPINA1 |
| Serum total protein level | intergenic |
| Serum total protein level | TNFRSF13B |
| Severe malaria | ABO |
| Severe malaria | HBB |
| Shingles | HCP5 |
| Sleeping time | PAX8, LOC101927400, CBWD2 |
| Sleeping time | FLOT1, LINC00243, IER3 |
| Smoking amount | CCK |
| Smoking amount | COMT |
| Telomere length | TERC |
| Telomere length | OBFC1 |
| Telomere length | CTC1 |
| Testicular cancer | CENPE |
| Testicular cancer | TERT, CLPTM1L |
| Testicular cancer | SPRY4 |
| Testicular cancer | BAK1 |
| Testicular cancer | DMRT1 |
| Testicular cancer | ATF7IP |
| Testicular cancer | KITLG |
| Testicular cancer | RFWD3 |
| Testicular cancer | TEX14 |
| Testosterone levels | SHBG |
| Thyroid cancer | DIRC3 |
| Thyroid cancer | FOXE1 |
| Thyroid cancer | NKX2-1 |
| Thyroid hormone (T4) levels | DIO1 |
| Thyroid hormone (T4) levels | AADAT |
| Thyroid hormone (T4) levels | FOXE1 |
| Thyroid hormone (T4) levels | LHX3 |
| Triglycerides | ANGPTL3 |
| Triglycerides | GCKR |
| Triglycerides | MLXIPL |
| Triglycerides | LPL |
| Triglycerides | TRIB1 |
| Triglycerides | APOA1, APOC3, APOA4, APOA5 |
| Tuberculosis | ASAP1 |
| Tuberculosis | WT1 |
| Type 2 diabetes | IGF2BP2 |
| Type 2 diabetes | CDKAL1 |
| Type 2 diabetes | MIR129, LEP |
| Type 2 diabetes | SLC30A8 |
| Type 2 diabetes | CDKN2A, CDKN2B |
| Type 2 diabetes | HHEX |
| Type 2 diabetes | TCF7L2 |
| Type 2 diabetes | KCNQ1 |
| Type 2 diabetes | C2CD4B, C2CD4A |
| Type 2 diabetes | SLC16A13 |
| Type 2 diabetes | DUSP9 |
| Type 2 diabetes nephropathy | ELMO1 |
| Ulcerative colitis | FCGR2A |
| Ulcerative colitis | HLA |
| Urate levels | GCKR |
| Urate levels | LRP2 |
| Urate levels | SLC2A9 |
| Urate levels | ABCG2 |
| Urate levels | SLC22A12 |
| Urate levels | LOC101928230 |
| Uterine fibroids | OBFC1, SLK |
| Uterine fibroids | ODF3, RIC8A, SIRT3, BET1L |
| Uterine fibroids | TNRC6B |
| Venous thromboembolism | F5 |
| Venous thromboembolism | FGG |
| Venous thromboembolism | F11 |
| Venous thromboembolism | ABO |
| Venous thromboembolism | TSPAN15 |
| Venous thromboembolism | SLC44A2 |
| Visceral adipose tissue/subcutaneous adipose tissue ratio | LYPLAL1 |
| Visceral adipose tissue/subcutaneous adipose tissue ratio | NISCH |
| Visceral fat | NISCH |
| Vitamin B12 levels | none |
| Vitamin B12 levels | MS4A3 |
| Vitamin B12 levels | CLYBL |
| Vitamin B12 levels | FUT6 |
| Vitamin B12 levels | FUT2 |
| Vitamin D levels | GC |
| Vitamin D levels | CYP2R1 |
| Vitamin D levels | DHCR7 |
| Vitiligo | HLA-A |
| Vogt-Koyanagi-Harada syndrome | C1orf141, IL23R |
| Vogt-Koyanagi-Harada syndrome | HLA-DRB1, HLA-DQA1 |
| Vogt-Koyanagi-Harada syndrome | EGR2, ADO, ZNF365 |
| White blood cell count | PSORS1C1, CDSN, MHC |
| White blood cell count | HBS1L, MYB |
| White blood cell count | CDK6 |
| White blood cell count | RAP1B, NUP107, SLC35E3 |
| White blood cell count | CSF3, PSMD3, MED24, GSDMA |
| Wine liking | HLA-DOA |
| Wilms tumor | DDX1 |
| Wilms tumor | none |
| Wilms tumor | DLG2 |
| Evening Preference | CLOCK |
| Evening Preference | NPSR1 |
| Sleep Bruxism | HTR2A |
| Caffeine Metabolism | CYP1A2 |
| Caffeine-induced Anxiety | ADORA2A |
| Sweet Preference | LEPR |
| Sweet Preference | ADIPOQ |
| Sweet Preference | LEP |
| Hippocampal Volume | BDNF |
| Hippocampal Volume | TPH2 |
| Hippocampal Volume | none |
| Amygdala Volume | TPH2 |
| Pain Sensitivity | LEP |
| Pain Sensitivity | COMT |
| Taste sensitivity (Phenylthiocarbamide) | TAS2R38 |
| Odor Detection (isovaleric acid) | OR11H7 |
| Mathematics Ability | FLJ20160 |
| Mathematics Ability | DNAH5 |
| Mathematics Ability | SAMD3 |
| Mathematics Ability | ARID1B |
| Mathematics Ability | DLD |
| Mathematics Ability | NRCAM |
| Mathematics Ability | MMP7 |
| Mathematics Ability | GUCY1A2 |
| Mathematics Ability | NUAK1 |
| Mathematics Ability | GRIK1 |
| Memory Performance | KIBRA |
| Memory Performance | DTNBP1 |
| Memory Performance | PAH |
| Musical Ability | UGT8 |
| Aging (brain performance) | FKBP5 |
| Aging (brain performance) | BDNF |
| Skin Type | GPX1 |
| Skin Type | SOD2 |
| Skin Type | MMP1 |
| Vitamin A Level | RBP4 |
| Vitamin A Level | TTR |
| Vitamin B6 Level | NBPF3（ALPL) |
| Vitamin E Level | ZNF259 |
| Vitamin E Level | SCARB1 |
| Vitamin E Level | CYP4F2 |
| Iron Level | HFE |
| Iron Level | TFR2 |
| Iron Level | TMPRSS6 |
| Beta-carotene Level | BCMO1 |
| Alpha-linolenic Acid Level | C11orf9 |
| Alpha-linolenic Acid Level | C11orf10 |
| Alpha-linolenic Acid Level | FEN1 |
| Alpha-linolenic Acid Level | FADS1 |
| Alpha-linolenic Acid Level | FADS2 |
| DHA/EPA Level | ELOVL2 |
| Alcohol Flush | ALDH2 |
| Alcohol Metabolism | ADH6, ADH1B |
| Blood Pressure Change by Salt Intake | CYP3A5 |
| Blood Pressure Change by Salt Intake | AGT |
| Permanent Tooth Eruption | CACNA1S |
| Permanent Tooth Eruption | TNP1 |
| Permanent Tooth Eruption | ADK |
| Permanent Tooth Eruption | HMGA2 |
| Primary Tooth Eruption | MSRB3 |
| Primary Tooth Eruption | RAD51L1 |
| Primary Tooth Eruption | IGF2BP1 |
| Primary Tooth Eruption | KCNJ2 |
| Primary Tooth Eruption | EDA |
| Erectile Dysfunction (ED) | GNB3 |
| Norovirus Infection | FUT2 |
| Hair morphology | EDAR |
| Hair morphology | FGFR2 |
| Muscle Type | ACTN3 |
| Exercise (Anaerobic performance) | CNTF |
| Exercise (Anaerobic performance) | ACTN3 |
| Exercise (Anaerobic performance) | ACE |
| Metabolism of acrylamide | EPHX1 |
| Odor detection (2-heptanone) | LOC105373996 |
| Odor detection (isobutyraldehyde) | NDUFA10 |
| Odor detection (β-damascenone) | OR5BN1P |
| Odor detection (β-ionone) | OR4D6 |
| Meningococcal disease | CFH |
| Meningococcal disease | CFHR3 |
| Breast Size | INHBB |
| Breast Size | AREG |
| Breast Size | ESR1 |
| Breast Size | ZNF703 |
| Breast Size | ZNF365 |
| Breast Size | PTHLH |
| Infantile Hypertrophic Pyloric Stenosis | MBNL1 |
| Infantile Hypertrophic Pyloric Stenosis | none |
| Infantile Hypertrophic Pyloric Stenosis | BNIP1, NKX2-5 |
| Infantile Hypertrophic Pyloric Stenosis | LINC01312, TARID |
| Infantile Hypertrophic Pyloric Stenosis | SIK3 |
| Infantile Hypertrophic Pyloric Stenosis | LDLR |
| photic sneeze reflex | ZEB2 |
| Skin reflectance | MC1R |
| Platelet aggregation (ADP) | PEAR1 |
| Platelet aggregation (ADP) | SHH |
| Platelet aggregation (ADP) | MRVI1 |
| Platelet aggregation (epinephrine) | PEAR1 |
| Platelet aggregation (epinephrine) | PIK3CG |
| Platelet aggregation (epinephrine) | JMJD1C |
| Platelet aggregation (epinephrine) | ADRA2A |
| Platelet aggregation (collagen) | GP6 |
| Early onset of hypertension | ACE |
| Age at Menarche | LIN28B |
| Age at Menarche | TMEM38B |
| Y-Chromosome Haplo type | SRY |
| Y-Chromosome Haplo type | RPS4Y1 |
| Y-Chromosome Haplo type | ZFY |
| Y-Chromosome Haplo type | USP9Y |
| Y-Chromosome Haplo type | DDX3Y |
| Y-Chromosome Haplo type | UTY |
| Y-Chromosome Haplo type | LOC105377223 |
| Y-Chromosome Haplo type | KDM5D |
| Y-Chromosome Haplo type | none |
| Risk for fracture | SPTBN1 |
| Risk for fracture | MEPE |
| Risk for fracture | SLC25A13 |
| Risk for fracture | LRP5 |
| Risk for fracture | C18orf19 |
| Subcutaneous Fat | FTO |
| Androsterone sulfate levels | CYP3A5 |
| Androsterone sulfate levels | ZCWPW1 |
| Androsterone sulfate levels | SULT2A1 |
| Glycine levels | CPS1 |
| Aspartylphenylalanine levels | ACE |
| Serine levels | PHGDH |
| Serine levels | CPS1 |
| Serine levels | PSPH |
| Inosine levels | NT5E |
| Proline levels | PRODH |
| Glutamine levels | GLS2 |
| Carnitine levels | ALX3 |
| Carnitine levels | PEX5L |
| Carnitine levels | SLC22A4 |
| Carnitine levels | SLC16A9 |
| Information processing -Digit symbol (DS)- | CADM2 |
| Information processing -Digit symbol (DS)- | ATRNL1 |
| Information processing -Digit symbol (DS)- | AC015574.1 |
| Information processing -Digit symbol (DS)- | AC015574.2 |
| Information processing -Digit symbol (DS)- | KRTAP7-1 |
| Information processing -Symbol search (SS)- | SH3RF3 |
| Information processing -Symbol search (SS)- | NFKBIL1 |
| Information processing -Symbol search (SS)- | RSU1 |
| Information processing -Inspection time (IT)- | AC007652.1 |
| Information processing -Inspection time (IT)- | CRTC3 |
| Information processing -Inspection time (IT)- | DNAI2 |
| Information processing -Inspection time (IT)- | RP4-697P8.2/LOC101929413 |
| Information processing -Simple RT (SRT)- | EXTL2P1 |
| Information processing -Simple RT (SRT)- | MYRIP |
| Information processing -Simple RT (SRT)- | C9orf5 |
| Information processing -Simple RT (SRT)- | AC007450.3 |
| Information processing -Simple RT (SRT)- | TTC7B |
| Information processing -Simple RT (SRT)- | AC109462.1 |
| Information processing -2-choice RT- | LOC105377097 |
| Information processing -2-choice RT- | NRSN1 |
| Information processing -2-choice RT- | DCDC2 |
| Information processing -2-choice RT- | intergenic |
| Information processing -2-choice RT- | AP005434.1 |
| Information processing -2-choice RT- | SPATA7 |
| Information processing -2-choice RT- | C20orf196 |
| Information processing -4-choice RT- | FAM110C |
| Information processing -4-choice RT- | RP11-358M3.1 |
| Information processing -4-choice RT- | AC022274.1 |
| Information processing -4-choice RT- | DIP2C |
| Information processing -4-choice RT- | KCTD2 |
| Information processing -8-choice RT- | LAPTM4A |
| Information processing -8-choice RT- | AC098828.2 |
| Information processing -8-choice RT- | none |
| Information processing -8-choice RT- | C6orf220 |
| Information processing -8-choice RT- | intergenic |
| Information processing -8-choice RT- | RAB11FIP2 |
| Information processing -Speed Factor- | CTC-430J12.2 |
| Information processing -Speed Factor- | none |
| Information processing -Speed Factor- | PDE1C |
| Information processing -Speed Factor- | TRIB3 |
| Information processing -Speed Factor- | PKNOX1 |
| Valine levels | PPM1K |
| Phenylalanine levels | PAH |
| Ear protrusion | EDAR |
| Ear lobe size | EDAR |
| Ear lobe size | LOC100130256 |
| Ear lobe size | MRPS22 |
| Ear lobe size | LOC153910 |
| Ear helix rolling | EDAR |
| Ear helix rolling | LRBA |
| Protein intake | FTO |
| Carbohydrate or Fat intake | IZUMO1 |
| Eye color | OCA2 |
| Eye color | HERC2 |
| Bitter sensitivity (Caffeine) | TAS2R46 |
| Bitter sensitivity (Quinine) | TAS2R19 |
| Bitter sensitivity | TAS2R38 |
| Pericardial fat | TRIB2 |
| Galectin levels | ABO |
| Galectin levels | LGALS3 |
| Urea nitrogen levels | MTX1-GBA |
| Urea nitrogen levels | PAX8 |
| Urea nitrogen levels | LRIG1-KBTBD8 |
| Urea nitrogen levels | MECOM |
| Urea nitrogen levels | UNCX |
| Urea nitrogen levels | MPPED2-DCDC5 |
| Urea nitrogen levels | C12orf51 |
| Urea nitrogen levels | WDR72 |
| Urea nitrogen levels | BCAS3 |
| Urea nitrogen levels | SLC14A2 |
| Urea nitrogen levels | GNAS |
| Creatinine level | SHROOM3 |
| Creatinine level | MHC |
| Creatinine level | UNCX |
| Creatinine level | MPPED2-DCDC5 |
| Creatinine level | ALDH2 |
| Creatinine level | WDR72 |
| Creatinine level | UMOD |
| Creatinine level | TBX2 |
| eGFRcreat | SHROOM3 |
| eGFRcreat | MHC |
| eGFRcreat | UNCX |
| eGFRcreat | MPPED2-DCDC5 |
| eGFRcreat | WDR72 |
| eGFRcreat | UMOD |
| eGFRcreat | BCAS3 |
| Shovel-shaped incisors | EDAR |
| Shovel-shaped incisors | WNT10A |
| Molar size | WNT10A |
| Sperm production | CYP19A1 |
| Carotid intima media thickness | GCKR |
| Carotid intima media thickness | PINX1 |
| Carotid intima media thickness | ZHX2 |
| Carotid intima media thickness | APOC1 |
| Carotid plaque (Atheroma) | EDNRA |
| Carotid plaque (Atheroma) | PIK3CG |
| Thyroid volume | CAPZB |
| Thyroid volume | FGF7 |
| Thyroid volume | LOC105371356 |
| Otosclerosis | RELN |
| Otosclerosis | BMP4 |
| Otosclerosis | BMP2 |
| Digit length ratio | SMOC1 |
| Fischer ratio | PPM1K |
| Fischer ratio | SLC2A4 |
| Waist-Hip ratio (for women) | TBX15 |
| Waist-Hip ratio (for women) | DNM3 |
| Waist-Hip ratio (for women) | LYPLAL1 |
| Waist-Hip ratio (for women) | ETAA1 |
| Waist-Hip ratio (for women) | GRB14 |
| Waist-Hip ratio (for women) | PLXND1 |
| Waist-Hip ratio (for women) | HLA-DRB5 |
| Waist-Hip ratio (for women) | VEGFA |
| Waist-Hip ratio (for women) | MSC |
| Waist-Hip ratio (for women) | ABCA1 |
| Waist-Hip ratio (for women) | CEP120 |
| Waist-Hip ratio (for women) | NID2 |
| Waist-Hip ratio (for women) | CMIP |
| Waist-Hip ratio (for women) | KCNJ2 |
| Waist-Hip ratio (for Men) | FGFR4 |
| Waist-Hip ratio (for Men) | GDF5 |
| Hip size (for women) | KLF14 |
| Hip size (for women) | SFXN2 |
| Waist circumstance (for women) | ADAMTSL3 |
| Waist circumstance (for women) | EFEMP1 |
| Waist circumstance (for men) | EFEMP1 |
| Osteosarcoma | RASSF1A |
| Osteosarcoma | IL16 |
| Renal cell carcinoma | EPAS1 |
| Renal cell carcinoma | none |
| Renal cell carcinoma | MMP1 |
| Renal cell carcinoma | MMP3 |
| Renal cell carcinoma | VDR |
| Renal cell carcinoma | SCARB1 |
| Renal cell carcinoma | IL16 |
| Recurrent aphthous stomatitis | SELE |
| Lean body mass | PRDM16 |
| Seasonal rhinitis (cedar pollen) | ADAM33 |
| Vitamin D insufficiency | GC |
| Vitamin D insufficiency | CYP2R1 |
| Vitamin D insufficiency | DHCR7 |
| High-altitude pulmonary edema | EPAS1 |
| High-altitude pulmonary edema | NOS3 |
| High-altitude pulmonary edema | ACE |
| High-altitude pulmonary edema | TIMP3 |
| Pediatric acute lymphoblastic leukemia with MLL fusion gene | NQO1 |
| Systolic blood pressure | GRB14, FIGN |
| Systolic blood pressure | FGF5 |
| Systolic blood pressure | NPR3 |
| Systolic blood pressure | NT5C2, CNNM2, CYP17A1 |
| Systolic blood pressure | ATP2B1 |
| Systolic blood pressure | RPL6, ALDH2, PTPN11 |
| Basophil count | SLC45A3-NUCKS1 |
| Basophil count | GATA2 |
| Basophil count | NAALAD2 |
| Basophil count | ERG |
| Lip shape | IRF6 |
| Left venticular internal diastolic dimensions | SLC35F1 |
| Left venticular internal diastolic dimensions | C6orf204, PLN |
| Aortic root size | CCDC100 |
| Aortic root size | PDE3A |
| Aortic root size | HMGA2 |
| Aortic root size | SMG6 |
| Aortic root size | SRR |
| Thyroid-stimulating hormone levels | IGFBP5 |
| Thyroid-stimulating hormone levels | NR3C2 |
| Thyroid-stimulating hormone levels | PDE8B |
| Thyroid-stimulating hormone levels | VEGFA |
| Thyroid-stimulating hormone levels | SASH1 |
| Thyroid-stimulating hormone levels | PDE10A |
| Thyroid-stimulating hormone levels | NRG1 |
| Thyroid-stimulating hormone levels | XKR4 |
| Thyroid-stimulating hormone levels | GLIS3 |
| Thyroid-stimulating hormone levels | FOXE1 |
| Thyroid-stimulating hormone levels | PRDM11 |
| Thyroid-stimulating hormone levels | MBIP |
| Thyroid-stimulating hormone levels | ITPK1 |
| Thyroid-stimulating hormone levels | FGF7 |
| Thyroid-stimulating hormone levels | MIR1179 |
| Thyroid-stimulating hormone levels | LOC440389, MAF |
| Thyroid-stimulating hormone levels | SOX9 |
| Thyroid-stimulating hormone levels | INSR |
| Optic disc area | CDC7 |
| Optic disc area | ATOH7, PBLD |
| Optic disc area | LOC102723323 |
| Optic disc area | CARD10 |
| Androgenetic alopecia | none |
| Intra-cranial volume | none |
| Intra-cranial volume | KANSL1 |
| Hypospadias | HSD17B3 |
| Hypospadias | DGKK |
| Hashimoto thyroiditis | VAV3 |
| Hashimoto thyroiditis | GPR103 |
| Graves ophthalmopathy | BCL2L15 |
| Skin color | TYR |
| Skin color | OCA2 |
| Skin color | SLC45A2 |
| Birth weight | ADCY5 |
| Birth weight | CCNL1 |
| Birth weight | LCORL |
| Birth weight | none |
| Birth weight | CDKAL1 |
| Birth weight | ADRB1 |
| Birth weight | HMGA2 |
| Essential tremor | LRRK2 |
| Third molar agenesis | THSD7B |
| Third molar agenesis | LOC100420828 |
| Third molar agenesis | LOC100507548 |
| Hearing function | SLC28A3 |
| Hearing function | PCDH20 |
| Effect of cold shock on Blood pressure | AGT |
| Effect of cold shock on Blood pressure | AGTR1 |
| Effect of cold shock on Blood pressure | ACE2 |
| Taste sensitivity (Umami) | TAS1R3 |
| Taste sensitivity (Umami) | TAS1R1 |
| Ankle-brachial index (ABI) | ANRIL |
| Ankle-brachial index (ABI) | BRAP |
| Nasion position | PAX3 |
| Infant head circumference | HMGA2 |
| Infant head circumference | SBNO1 |
| Infant head circumference | CRHR1-MAPT |
| Glaucoma (primary angle closure) | COL11A1 |
| Glaucoma (primary angle closure) | PLEKHA7 |
| Plasma resistin levels | RETN |
| Oligospermia | OR2W3 |
| Oligospermia | PSAT1 |
| Oligospermia | USP8 |
| R wave voltage in V5 | Tbx3 |
| Cardiac troponin T levels | NCOA2 |
| Task specific dystonia | ARSG |
| Iron-deficiency anemia | TMPRSS6 |
| Lactose intolerance | MCM6 |
| Grip strength | none |
| Plasma Tissue Plasminogen Activator levels | STXBP5 |
| Plasma Tissue Plasminogen Activator levels | PLAT |
| Plasma Tissue Plasminogen Activator levels | STX2 |
| Plasma plasminogen levels | PLG |
| Plasma plasminogen levels | SIGLEC14 |
| Sitting height ratio | BCKDHB |
| Sitting height ratio | IGFBP3 |
| Sitting height ratio | TBX2 |
| Sitting height ratio | PTPRM |
| Sitting height ratio | NFATC2 |
| Enteric fever | HLA-DRB1 |
| IgA levels | TNFSF13 |
| Forced expiratory volume in 1 second (FEV1) | TNS1 |
| Forced expiratory volume in 1 second (FEV1) | EVI1 |
| Forced expiratory volume in 1 second (FEV1) | GSTCD |
| Forced expiratory volume in 1 second (FEV1) | HTR4 |
| Forced expiratory volume in 1 second (FEV1) | ZKSCAN3 |
| Forced expiratory volume in 1 second (FEV1) | CDC123 |
| Forced expiratory volume in 1 second (FEV1) | C10orf11 |
| FEV1/FVC | MFAP2 |
| FEV1/FVC | TGFB2 |
| FEV1/FVC | HDAC4 |
| FEV1/FVC | RARB |
| FEV1/FVC | HHIP |
| FEV1/FVC | SPATA9 |
| FEV1/FVC | AGER |
| FEV1/FVC | DAAM2 |
| FEV1/FVC | ARMC2 |
| FEV1/FVC | CDC123 |
| FEV1/FVC | LRP1 |
| FEV1/FVC | CCDC38 |
| FEV1/FVC | THSD4 |
| FEV1/FVC | MMP15 |
| FEV1/FVC | CFDP1 |
| FEV1/FVC | KCNE2 |
| Diffuse-Type Gastric Cancer | MUC1 |
| Diffuse-Type Gastric Cancer | PSCA |
| Bone mineral density (Femoral neck) | ZBTB40 |
| Bone mineral density (Femoral neck) | WLS |
| Bone mineral density (Femoral neck) | DNM3 |
| Bone mineral density (Femoral neck) | GALNT3 |
| Bone mineral density (Femoral neck) | CTNNB1 |
| Bone mineral density (Femoral neck) | MEPE |
| Bone mineral density (Femoral neck) | MEF2C |
| Bone mineral density (Femoral neck) | C6orf97 |
| Bone mineral density (Femoral neck) | SLC25A13 |
| Bone mineral density (Femoral neck) | WNT16 |
| Bone mineral density (Femoral neck) | TNFRSF11B |
| Bone mineral density (Femoral neck) | FUBP3 |
| Bone mineral density (Femoral neck) | SOX6 |
| Bone mineral density (Femoral neck) | ARHGAP1 |
| Bone mineral density (Femoral neck) | AKAP11 |
| Bone mineral density (Femoral neck) | RPS6KA5 |
| Bone mineral density (Femoral neck) | MARK3 |
| Bone mineral density (Femoral neck) | C16orf38 |
| Bone mineral density (Femoral neck) | SALL1 |
| Bone mineral density (Femoral neck) | SMG6 |
| Bone mineral density (Femoral neck) | C17orf53 |
| Bone mineral density (lumbar spine) | ZBTB40 |
| Bone mineral density (lumbar spine) | WLS |
| Bone mineral density (lumbar spine) | SPTBN1 |
| Bone mineral density (lumbar spine) | GALNT3 |
| Bone mineral density (lumbar spine) | CTNNB1 |
| Bone mineral density (lumbar spine) | IDUA |
| Bone mineral density (lumbar spine) | MEPE |
| Bone mineral density (lumbar spine) | C6orf97 |
| Bone mineral density (lumbar spine) | STARD3NL |
| Bone mineral density (lumbar spine) | SLC25A13 |
| Bone mineral density (lumbar spine) | WNT16 |
| Bone mineral density (lumbar spine) | TNFRSF11B |
| Bone mineral density (lumbar spine) | MPP7 |
| Bone mineral density (lumbar spine) | KCNMA1 |
| Bone mineral density (lumbar spine) | LRP5 |
| Bone mineral density (lumbar spine) | DHH |
| Bone mineral density (lumbar spine) | SP7 |
| Bone mineral density (lumbar spine) | HOXC6 |
| Bone mineral density (lumbar spine) | AKAP11 |
| Bone mineral density (lumbar spine) | AXIN1 |
| Bone mineral density (lumbar spine) | TNFRSF11A |
| Bone mineral density (lumbar spine) | JAG1 |
| Preeclampsia | INHBB |
| Hematocrit | HBS1L, MYB |
| Hematocrit | ABO |
| Creatine kinase level | CD163 |
| Antioxidant synthesis | NQO1 |
| Antioxidant enzyme activity | MnSOD |
| Osmidrosis | ABCC11 |
| Extramammary Paget diseases | XRCC1 |
| Anti-Müllerian hormone levels | AMHR2 |
| Exercise capacity (aerobic performance) | PPARGC1A |
| Exercise capacity (aerobic performance) | PPARD |
| Exercise capacity (aerobic performance) | ATP6 |
| Coronary heart disease in hypercholesterolemia | ACE |
| Odor detection (Asparagus metabolites) | OR2M7, OR14C36 |
| Alanine levels | GCKR |
| Histidine levels | SLC2A9 |
| Leucine levels | PPM1K |
| Tryptophan levels | TDO2 |
| Tryptophan levels | SLC16A10 |
| Citrate levels | ANKH |
| Citrate levels | SLC13A5 |
| Tyrosine levels | SLC16A10 |
| Asparagine levels | ASPG |
| Lysine levels | SLC7A6 |
| Pupillary light reflex | OPN4 |
| Diet (for Men) | UCP1 |
| Diet (for Men) | ADRB2 |
| Diet (for Men) | ADRB3 |
| Diet (for Women) | UCP1 |
| Diet (for Women) | ADRB2 |
| Diet (for Women) | ADRB3 |
| Mitochondria Haplo group | - |
| Pediatric Nephrotic Syndrome | IL4 |
